Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.28
- Piotroski Score 2.00
- Grade Buy
- Symbol (ABOS)
- Company Acumen Pharmaceuticals, Inc.
- Price $2.97
- Changes Percentage (0.67%)
- Change $0.02
- Day Low $2.96
- Day High $2.97
- Year High $5.09
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/13/2024
- Fiscal Year End N/A
- Average Stock Price Target $7.00
- High Stock Price Target $7.00
- Low Stock Price Target $7.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.05
- Trailing P/E Ratio -2.5
- Forward P/E Ratio -2.5
- P/E Growth -2.5
- Net Income $-52,371,000
Income Statement
Quarterly
Annual
Latest News of ABOS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?
Islamic equity investing in debt-free Halal stocks has gained popularity among Muslim investors aligning with Shariah principles. Acumen Pharmaceuticals (NASDAQ: ABOS) is a promising buy with strong r...
By Yahoo! Finance | 4 months ago
